These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 23495227)

  • 1. Large-scale expansion of pre-isolated bone marrow mesenchymal stromal cells in serum-free conditions.
    Gottipamula S; Muttigi MS; Chaansa S; Ashwin KM; Priya N; Kolkundkar U; SundarRaj S; Majumdar AS; Seetharam RN
    J Tissue Eng Regen Med; 2016 Feb; 10(2):108-19. PubMed ID: 23495227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation, expansion and characterization of bone marrow-derived mesenchymal stromal cells in serum-free conditions.
    Gottipamula S; Ashwin KM; Muttigi MS; Kannan S; Kolkundkar U; Seetharam RN
    Cell Tissue Res; 2014 Apr; 356(1):123-35. PubMed ID: 24448665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Native extracellular matrix preserves mesenchymal stem cell "stemness" and differentiation potential under serum-free culture conditions.
    Rakian R; Block TJ; Johnson SM; Marinkovic M; Wu J; Dai Q; Dean DD; Chen XD
    Stem Cell Res Ther; 2015 Dec; 6():235. PubMed ID: 26620283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion and characterization of bone marrow derived human mesenchymal stromal cells in serum-free conditions.
    Bhat S; Viswanathan P; Chandanala S; Prasanna SJ; Seetharam RN
    Sci Rep; 2021 Feb; 11(1):3403. PubMed ID: 33564114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy.
    Li CY; Wu XY; Tong JB; Yang XX; Zhao JL; Zheng QF; Zhao GB; Ma ZJ
    Stem Cell Res Ther; 2015 Apr; 6(1):55. PubMed ID: 25884704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and prolonged expansion of oral mesenchymal stem cells under clinical-grade, GMP-compliant conditions differentially affects "stemness" properties.
    Bakopoulou A; Apatzidou D; Aggelidou E; Gousopoulou E; Leyhausen G; Volk J; Kritis A; Koidis P; Geurtsen W
    Stem Cell Res Ther; 2017 Nov; 8(1):247. PubMed ID: 29096714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory effects of rhesus monkey bone marrow-derived mesenchymal stem cells in serum-free conditions.
    Liu F; Li Y; Bai L; Yang Z; Liao G; Chen Y; Lu Y; Cheng J; Zhang J
    Int Immunopharmacol; 2018 Nov; 64():364-371. PubMed ID: 30245347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of human platelet lysate by use of ultrasound for ex vivo expansion of human bone marrow-derived mesenchymal stromal cells.
    Bernardi M; Albiero E; Alghisi A; Chieregato K; Lievore C; Madeo D; Rodeghiero F; Astori G
    Cytotherapy; 2013 Aug; 15(8):920-9. PubMed ID: 23623274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow.
    Bieback K; Hecker A; Kocaömer A; Lannert H; Schallmoser K; Strunk D; Klüter H
    Stem Cells; 2009 Sep; 27(9):2331-41. PubMed ID: 19544413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defined serum-free media for in vitro expansion of adipose-derived mesenchymal stem cells.
    Al-Saqi SH; Saliem M; Asikainen S; Quezada HC; Ekblad A; Hovatta O; Le Blanc K; Jonasson AF; Götherström C
    Cytotherapy; 2014 Jul; 16(7):915-26. PubMed ID: 24726655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro.
    Bochev I; Elmadjian G; Kyurkchiev D; Tzvetanov L; Altankova I; Tivchev P; Kyurkchiev S
    Cell Biol Int; 2008 Apr; 32(4):384-93. PubMed ID: 18262807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreas-derived mesenchymal stromal cells share immune response-modulating and angiogenic potential with bone marrow mesenchymal stromal cells and can be grown to therapeutic scale under Good Manufacturing Practice conditions.
    Thirlwell KL; Colligan D; Mountford JC; Samuel K; Bailey L; Cuesta-Gomez N; Hewit KD; Kelly CJ; West CC; McGowan NWA; Casey JJ; Graham GJ; Turner ML; Forbes S; Campbell JDM
    Cytotherapy; 2020 Dec; 22(12):762-771. PubMed ID: 32828673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human platelet lysate is an alternative to fetal bovine serum for large-scale expansion of bone marrow-derived mesenchymal stromal cells.
    Gottipamula S; Sharma A; Krishnamurthy S; Majumdar AS; Seetharam RN
    Biotechnol Lett; 2012 Jul; 34(7):1367-74. PubMed ID: 22476583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation, enumeration, and expansion of human mesenchymal stem cells in culture.
    Wagey R; Short B
    Methods Mol Biol; 2013; 946():315-34. PubMed ID: 23179841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum-free process development: improving the yield and consistency of human mesenchymal stromal cell production.
    Heathman TR; Stolzing A; Fabian C; Rafiq QA; Coopman K; Nienow AW; Kara B; Hewitt CJ
    Cytotherapy; 2015 Nov; 17(11):1524-35. PubMed ID: 26432558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of three-dimensional prospectively isolated mouse bone marrow mesenchymal stem/stromal cell aggregates on nanoculture plates.
    Obara C; Tomiyama K; Takizawa K; Islam R; Yasuda T; Gotoh T; Tajima K
    Cell Tissue Res; 2016 Oct; 366(1):113-27. PubMed ID: 27100525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effects of different culture media on the myogenic differentiation potential of adipose tissue- or bone marrow-derived human mesenchymal stem cells.
    Stern-Straeter J; Bonaterra GA; Juritz S; Birk R; Goessler UR; Bieback K; Bugert P; Schultz J; Hörmann K; Kinscherf R; Faber A
    Int J Mol Med; 2014 Jan; 33(1):160-70. PubMed ID: 24220225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human mesenchymal stem cells possess different biological characteristics but do not change their therapeutic potential when cultured in serum free medium.
    Wang Y; Wu H; Yang Z; Chi Y; Meng L; Mao A; Yan S; Hu S; Zhang J; Zhang Y; Yu W; Ma Y; Li T; Cheng Y; Wang Y; Wang S; Liu J; Han J; Li C; Liu L; Xu J; Han ZB; Han ZC
    Stem Cell Res Ther; 2014 Dec; 5(6):132. PubMed ID: 25476802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine Mesenchymal Stem Cell Potential and the Importance of Dog Breed: Implication for Cell-Based Therapies.
    Bertolo A; Steffen F; Malonzo-Marty C; Stoyanov J
    Cell Transplant; 2015; 24(10):1969-80. PubMed ID: 25375819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine and Equine Mesenchymal Stem Cells Grown in Serum Free Media Have Altered Immunophenotype.
    Clark KC; Kol A; Shahbenderian S; Granick JL; Walker NJ; Borjesson DL
    Stem Cell Rev Rep; 2016 Apr; 12(2):245-56. PubMed ID: 26638159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.